A common diabetes medication, metformin, slows the growth of precancerous cells in the esophagus while some metabolic ...
CALY-002 is under development for the treatment of eosinophilic esophagitis, celiac disease and unspecified dermatological disorders. It is a fully-humanized monoclonal antibody also administered ...
Lupin share price traded under selling pressure in Wednesday's trade to quote at Rs 2,230.60 per share on the NSE, down 1.75 ...
New Delhi: Home-grown pharma major Lupin Ltd on Wednesday said it has entered into a non-exclusive patent licence agreement ...
Medication-induced esophagitis, or pill esophagitis, develops when oral medications or supplements get stuck in the esophagus and damage esophageal tissues as they dissolve. Pill esophagitis is most ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...
The Eosinophilic Esophagitis Histology Scoring System (EoEHSS ... of 67% at 12 weeks, aligning with US Food and Drug ...
Eosinophilic Esophagitis Histology Scoring System ("EoEHSS ... Using data from four biopsy sites, which is consistent with the U.S. Food and Drug Administration ("FDA") Guidance for Developing ...
Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...
Doctors at the four hospitals—Ochsner Health, Tulane Medical Center, Mayo Clinic, and USC Keck—who evaluated me for a liver ...
(HealthDay News) — A history of upper gastrointestinal mucosal damage (MD) is associated with a higher subsequent risk for ...